This report does sound like a pitch for another CR . I was hoping the developed dialouge with a potential partner(s) the may have led to a deal . IMO a lowball upfront with decent royalties would be wiser than a CR anytime soon . This is platform science with a myriad of applications that would be commercially if not technically validated by a name partner . They want a partner now they say , there talking to pharma' they say . This is not the time to play hardball as I dont see the coy in a position of strength atm .
Bio report, page-7
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $16.54K | 5.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 96791453 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 58594028 | 16 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |